Comparing the area fraction (%Area) of risk genes in GBM patients, it was observed that LOXL1, LOXL4, and GUCA1A were significantly elevated in patients with an OS <15 months (Figure 8). This evidence concerns the gene LOXL1 and glioblastoma.